Wednesday, February 11, 2009 3:18:43 PM
To the contrary. Such an impressive collection of intellectual property, and products on the market (both consumer and forensic,) is not accumulated by "doing nothing." Also, your claim that, "There is no CEO in the world who could save this company, even if you could find one willing to try," is unsubstantiated.
DNAPrint Genomics and its technology has received a lot of praise, recognition, and general respect, from various parties. Its technology is routinely called "cutting edge." Only in the investment forums do you find constant negativity, coming from certain aliases. The "real world" respects DNAPrint Genomics' technology, and there have been recent, ongoing mentions of positive collaborations with the company, as well. Do some Google (and Google News, and Google Scholar,) searches. You'll see. These consistently positive references and mentions, do not paint a picture of a company that has merely been "doing nothing."
Daniel
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM